A paper titled Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study was published in April in BMC Neurology.
The study was conducted by analysts from Analysis Group Inc. (Boston, MA) and funded by Acadia.This study assessed the Rett patient population in the United States based on de-identified administrative healthcare claims data from 2016 to 2019 and using the RTT diagnosis code.
The study identified 5,940 eligible female Rett patients in the United States (paediatric: 3,078; adult: 2,862) , with a mean age of 20 years. A further 1320 males living with Rett syndrome were also identified but were not included in the study analysis.
That suggests ~7260 diagnosed Rett syndrome patients in the US all up.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071755/
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren and Acadia expand global partnership for trofinetide
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.08%
!
$12.53

Ann: Neuren and Acadia expand global partnership for trofinetide, page-125
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.53 |
Change
-0.010(0.08%) |
Mkt cap ! $1.563B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.34 | $1.908M | 152.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 130 | $12.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.53 | 508 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 489 | 12.530 |
3 | 378 | 12.520 |
3 | 1065 | 12.510 |
4 | 1297 | 12.500 |
3 | 1092 | 12.490 |
Price($) | Vol. | No. |
---|---|---|
12.560 | 521 | 3 |
12.570 | 544 | 3 |
12.580 | 1549 | 8 |
12.590 | 1361 | 4 |
12.600 | 2045 | 7 |
Last trade - 10.55am 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |